Yat Sun Or, Senior VP & CSO at ENANTA PHARMACEUTICALS INC (ENTA), sold 74,955 shares at $88.66 ($6.7M) on 2019-02-11, disclosed to the SEC on 2019-02-13.
Open-market sale of $6.7M ENTA by Senior VP & CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.66 | 5,835 | $517K | 7.7% |
| 2 | $88.66 | 5,835 | $517K | 7.7% |
| 3 | $89.50 | 18,971 | $1.7M | 25.3% |
| 4 | $89.50 | 18,971 | $1.7M | 25.3% |
| 5 | $90.11 | 2,707 | $244K | 3.6% |
| 6 | $90.11 | 2,707 |
| $244K |
| 3.6% |
| 7 | $91.24 | 171 | $16K | 0.2% |
| 8 | $91.24 | 171 | $16K | 0.2% |
| 9 | $88.88 | 6,993 | $622K | 9.3% |
| 10 | $90.07 | 6,297 | $567K | 8.5% |
| 11 | $90.07 | 6,297 | $567K | 8.5% |
| Total | $89.46 avg | 74,955 | $6.7M | 100% |
| Filing → |
| ENTA | SELL | 2023-12-06 | $23K | — | Filing → |
| ENTA | SELL | 2023-03-17 | $1.2M | — | Filing → |
| ENTA | SELL | 2019-03-04 | $2.1M | — | Filing → |